After Celgene buy, Bristol-Myers CEO ducks questions about rival - STAT

After Celgene buy, Bristol-Myers CEO ducks questions about rival - STAT

Having gobbled up Celgene, the Bristol-Myers CEO ducks questions about his key rival

By ED SILVERMAN

EMILIE PICKERING FOR STAT

“I think we’re just at the beginning of a long journey," said Bristol-Myers Squibb chief executive Giovanni Caforio about having acquiring Celgene.

READ MORE